Relationship between ivabradine treatment and cardiovascular outcomes in patients with stable coronary artery disease and left ventricular systolic dysfunction with limiting angina: a subgroup analysis of the randomized, controlled BEAUTIFUL trial

Efficacy of the If current inhibitor ivabradine in patients with chronic stable angina receiving beta-blocker therapy: a 4-month, randomized, placebo-controlled trial

(2009) J.-C. Tardif et al.   EUROPEAN HEART JOURNAL

Dosing of Beta-Blocker Therapy Before, During, and After Hospitalization for Heart Failure (from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure)

(2008) Gregg C. Fonarow et al.   AMERICAN JOURNAL OF CARDIOLOGY

Inducible Ischemia and the Risk of Recurrent Cardiovascular Events in Outpatients With Stable Coronary Heart DiseaseThe Heart and Soul Study

(2008) Anil K. Gehi   ARCHIVES OF INTERNAL MEDICINE

Defying the economists: a decrease in heart rate improves not only cardiac but also endothelial function

(2008) C R Triggle   BRITISH JOURNAL OF PHARMACOLOGY

Heart Rate Reduction by Ivabradine Reduces Oxidative Stress, Improves Endothelial Function, and Prevents Atherosclerosis in Apolipoprotein E–Deficient Mice

(2008) Florian Custodis et al.   CIRCULATION

Improvement of regional myocardial blood flow and function and reduction of infarct size with ivabradine: protection beyond heart rate reduction

(2008) G. Heusch et al.   EUROPEAN HEART JOURNAL

Do patients with angina alone have a more benign prognosis than patients with a history of acute myocardial infarction, revascularisation or both? Findings from a community cohort study

(2008) B Buckley et al.   HEART

Elevated heart rate and atherosclerosis: An overview of the pathogenetic mechanisms

(2008) George D. Giannoglou et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial

(2008) Kim Fox et al.   LANCET

Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial

(2008) Kim Fox et al.   LANCET